首页|妇康丸联合卡前列素氨丁三醇治疗产后宫缩乏力性出血的临床研究

妇康丸联合卡前列素氨丁三醇治疗产后宫缩乏力性出血的临床研究

扫码查看
目的 探究妇康丸联合卡前列素氨丁三醇治疗产后宫缩乏力性出血的临床效果与安全性。方法 选取2021年9月—2023 年9 月在郑州大学第五附属医院分娩后出现宫缩乏力性出血的产妇 116 例,根据治疗方案的差异分成对照组和治疗组,每组各 58 例。对照组子宫体注射卡前列素氨丁三醇注射液,首次注射剂量为 250 μg,15 min后仍见活动性出血则再次注射250 μg,总剂量控制在 2 mg以内。治疗组额外口服妇康丸,首次 9 g,相隔 6 h后再服用 9 g,此后每日早晚各服 9 g。两组均进行为期 5 d的治疗。观察两组患者临床疗效,比较治疗前后两组患者 24 h内出血量、止血时间和住院时间,血清 25-羟维生素 D[25-(OH)D]、D-二聚体(D-D)和转化生长因子-β1(TGF-β1)水平,及子宫复旧情况和不良反应情况。结果 治疗后,对照组和治疗组临床总有效率分别为 86。21%、96。55%,两组比较差异具有统计学意义(P<0。05)。治疗后,治疗组产妇24 h内出血量、止血时间及住院时间均明显短于对照组(P<0。05)。治疗后,两组产妇血清 25-(OH)D和TGF-β1 水平显著升高,而血清D-D水平均显著降低(P<0。05),且治疗组各指标改善显著优于对照组(P<0。05)。治疗后,两组产妇子宫三径之和和宫底高度均显著降低(P<0。05),且治疗组在各指标改善上显著优于对照组(P<0。05)。治疗过程中,对照组不良反应发生率为 34。48%,明显高于治疗组的 17。24%(P<0。05)。结论 妇康丸联合卡前列腺素氨丁三醇治疗产后宫缩乏力性出血疗效显著,不仅能够显著改善产妇出血症状并缩短住院时间,同时还能够促进子宫复旧和血清学指标的恢复。
Clinical study on Fukang Pills and carboprost tromethamine in treatment of postpartum uterine atony and hemorrhage
Objective To explore the therapeutic effect and safety of Fukang Pills and carboprost tromethamine in treatment of postpartum uterine atony and hemorrhage.Methods Patients(116 cases)with postpartum uterine atony and hemorrhage in the Fifth Affiliated Hospital of Zhengzhou University from September 2021 to September 2023 were divided into control and treatment group based on different treatments,and each group had 58 cases.Patients in the control group were iv administered with Carboprost Tromethamine Injection within the uterus,the first injection dose was 250 μg,if active bleeding was still seen 15 min later,250 μg was injected again,the total dose was controlled within 2 mg.Patients in the treatment group were po administered with Fukang Pills on the basis of the control group,the first time was 9 g,followed by 9 g 6 h apart,and then 9 g for twice daily.Patients in two groups were treated for 5 d.After treatment,the clinical evaluations were evaluated,the 24 h bleeding volume,hemostasis time,inpatient duration,serum 25-(OH)D,D-D,and TGF-β1 levels,postpartum uterus regression and adverse reactions in two groups before and after treatment were compared.Results After treatment,the total clinical effective rates of the control group and the treatment group were 86.21%and 96.55%,respectively,and the difference between the two groups was statistically significant(P<0.05).After treatment,the amount of bleeding in 24 h,hemostasis time,and hospital stay in the treatment group were significantly shorter than those in the control group(P<0.05).After treatment,the levels of serum 25-(OH)D and TGF-β1 of parturients in both groups were significantly increased,while the level of serum D-D was significantly reduced(P<0.05).And the levels of these indicators in the treatment group were better than those in the control group(P<0.05).After treatment,the sum of three uterine diameters and fundal height of parturients in both groups were significantly reduced,and which in the treatment group were significantly lower than those in the control group(P<0.05).During treatment,the incidence of adverse reactions(34.48%)in the control group was significantly higher than that(17.24%)in the treatment group(P<0.05).Conclusion The combination of Fukang Pills and carboprostaglandin tromethamine has a significant therapeutic effect on postpartum uterine atony and hemorrhage,which can not only significantly improve the bleeding symptoms of parturients and shorten hospital stay,but also promote uterine involution and the recovery of serological indicators.

Fukang PillsCarboprost Tromethamine Injectionpostpartum uterine atony hemorrhageuterine involution25-(OH)DD-D

赵志英

展开 >

郑州大学第五附属医院 产科,河南 郑州 450052

妇康丸 卡前列素氨丁三醇注射液 产后宫缩乏力性出血 子宫复旧 25-羟维生素D D-二聚体

河南省医学科技攻关计划联合共建项目

LHGJ20220567

2024

现代药物与临床
天津药物研究院,中国药学会

现代药物与临床

CSTPCD
影响因子:1.179
ISSN:1674-5515
年,卷(期):2024.39(10)
  • 7